Treatment of menstrual migraine by oestradiol implants.
Open Access
- 1 November 1983
- journal article
- research article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 46 (11), 1044-1046
- https://doi.org/10.1136/jnnp.46.11.1044
Abstract
The suppression of cyclical ovarian activity and the creation of constant oestradiol levels in blood by subcutaneous oestradiol implants has been used to treat 24 patients with menstrual migraine for up to five years. Twenty-three patients improved with treatment, 20 (83%) became completely or almost completely headache-free. Regular monthly periods were induced with cyclical oral progestogens. The treatment was not associated with any problems. The results support the concept that oestrogen withdrawal in the late luteal and menstrual phases of the ovarian cycle is the important precipitating factor in menstrual migraine, and such attacks can be prevented by suppressing the hormonal fluctuations associated with the ovarian cycle.Keywords
This publication has 11 references indexed in Scilit:
- MIGRAINE: A PLATELET DISORDERThe Lancet, 1981
- HORMONAL PROFILES IN POSTMENOPAUSAL WOMEN AFTER THERAPY WITH SUBCUTANEOUS IMPLANTSBJOG: An International Journal of Obstetrics and Gynaecology, 1981
- Procedures in practice. Hormone implantation.BMJ, 1980
- The climacteric.1977
- Implantation of pure crystalline pellets of estradiol for conception controlAmerican Journal of Obstetrics and Gynecology, 1977
- The role of estradiol withdrawal in the etiology of menstrual migraineNeurology, 1972
- Epidemiology of headache and migraine in womenJournal of Neurology, Neurosurgery & Psychiatry, 1971
- Arteriole alteration in normal and hyperplastic endometriumAmerican Journal of Obstetrics and Gynecology, 1968
- Relation between Headaches from Oral Contraceptives and Development of Endometrial ArteriolesBMJ, 1968
- ALLERGY TO OESTRONE IN CASES OF MIGRAINEActa Endocrinologica, 1950